Hubei Cancer Hospital ( Site 8014)

Wuhan, Hubei 430079

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Esophageal Squamous Cell Carcinoma

Studies at this site

• Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014) — Completed